0001213900-11-006480.txt : 20111202 0001213900-11-006480.hdr.sgml : 20111202 20111202160627 ACCESSION NUMBER: 0001213900-11-006480 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111201 FILED AS OF DATE: 20111202 DATE AS OF CHANGE: 20111202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HORGAN KEVIN CENTRAL INDEX KEY: 0001510614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 111240472 MAIL ADDRESS: STREET 1: C/O SOLIGENIX, INC. STREET 2: 29 EMMONS DRIVE, STE. C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 f4120111horgan_soligenix.xml OWNERSHIP DOCUMENT X0304 4 2011-12-01 0 0000812796 SOLIGENIX, INC. SNGX 0001510614 HORGAN KEVIN 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 0 1 0 0 Sr VP, Chief Medical Officer Stock Option (Right to Buy) 0.032 2011-12-01 4 A 0 1200000 0 A 2011-12-01 2021-11-30 Common Stock 1200000 1200000 D The option vests immediately as to 300,000 shares and vests as to the remainder of the shares on each three (3) month anniversary of December 1, 2011 at a rate of 75,000 shares per quarter thereafter. The exercise price of the option equals $0.032 per share, the market price of the Company's common stock as of the close of business on December 1, 2011. /s/ Kevin Horgan 2011-12-02